One-year study evaluating efficacy of an iodine-restricted diet for the treatment of moderate-to-severe hyperthyroidism in cats

被引:8
|
作者
Loftus, John P. [1 ]
DeRosa, Sage [1 ]
Struble, Angela M. [1 ]
Randolph, John F. [1 ]
Wakshlag, Joseph J. [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA
关键词
feline; thyroxine; free T4; nuclear scintigraphy; iodine; FELINE; FOOD; MANAGEMENT; DISEASE; SCORE;
D O I
10.2147/VMRR.S189709
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Purpose: This study sought to determine the efficacy of a therapeutic iodine-restricted diet during a 12 -month interval in cats with moderately to severely increased total thyroxine (TT4) concentrations. Patients and methods: Eight hyperthyroid cats with serum creatinine <2.0 mg/dL and TT4 >6.0 mu g/dL (reference interval 1.5-4.0 mu g/dL) were enrolled. Each cat underwent an initial physical examination, complete blood count, serum chemistry panel, thyroid profile, thyroid scintigraphy, and echocardiogram. Physical examination and all blood samplings were repeated at 1, 2, 3, 6, and 12 months after enrollment. Clients were instructed to feed only the therapeutic iodine-restricted diet throughout the entire study. Results: Median TT4 was 8.4 (range 6.2-24.0) mu g/dL at study onset. Thyroid scintigraphy was abnormal in all cats, confirming hyperthyroidism. Six out of eight cats had normal serum TT4 after 4 weeks of feeding the therapeutic diet. The two cats that did not achieve normalization of TT4 at 4 weeks had the highest initial TT4 concentrations. Three cats were withdrawn from the study due to emergence of chronic kidney disease. Conclusion: An iodine-restricted diet was able to control moderate-to-severe hyperthyroidism in most (six out of eight) of the cats by 4 weeks. Cats with highest baseline TT4 took substantially longer before TT4 concentrations normalized, if at all.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 50 条
  • [41] VitaFlow™ transcatheter valve system in the treatment of severe aortic stenosis: One-year results of a multicenter study
    Zhou, Daxin
    Pan, Wenzhi
    Wang, Jianan
    Wu, Yongjian
    Chen, Mao
    Modine, Thomas
    Mylotte, Darren
    Piazza, Niccolo
    Ge, Junbo
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 (02) : 332 - 338
  • [42] Involuntary outpatient treatment in patients with severe mental illness: A one-year follow-up study
    Lera-Calatayud, G.
    Hernandez-Viadel, M.
    Bellido-Rodriguez, C.
    Canete-Nicolas, C.
    Asensio-Pascual, P.
    Calabuig-Crespo, R.
    Leal-Cercos, C.
    [J]. INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2014, 37 (03) : 267 - 271
  • [43] Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH
    Chung, B-H
    Roehrborn, C. G.
    Siami, P.
    Major-Walker, K.
    Morrill, B. B.
    Wilson, T. H.
    Montorsi, F.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (02) : 152 - 159
  • [44] Secukinumab shows high and sustained efficacy in patients with moderate-to-severe palmoplantar psoriasis: 2.5-year results from the GESTURE study
    Gottlieb, A.
    Sullivan, J.
    Kubanov, A.
    You, R.
    Regnault, P.
    Frueh, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E261 - E261
  • [45] Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH
    B-H Chung
    C G Roehrborn
    P Siami
    K Major-Walker
    B B Morrill
    T H Wilson
    F Montorsi
    [J]. Prostate Cancer and Prostatic Diseases, 2009, 12 : 152 - 159
  • [46] Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions
    Ren, Fengmei
    Gong, Hui
    Zhang, Han
    Zhang, Xiaoguang
    Liu, Xiaolin
    Gao, Peifeng
    Li, Junying
    Zhang, Guisen
    [J]. MEDICAL SCIENCE MONITOR, 2023, 29
  • [47] EFFICACY OF BARICITINIB IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS WITH 3 YEARS OF TREATMENT: RESULTS FROM A LONG-TERM STUDY
    Bird, Paul
    Smolen, Josef S.
    Xie, Li
    Jia, Bochao
    Taylor, Peter C.
    Burmester, Gerd
    Tanaka, Yoshiya
    Elias, Ayesha
    Cardoso, Anabela
    Ortmann, Rob
    Walls, Chad
    Dougados, Maxime
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 : 23 - 23
  • [48] Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study
    Caporali, Roberto
    Taylor, Peter C.
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Bello, Natalia
    Zaremba-Pechmann, Liliana
    Fang, Ying
    Dougados, Maxime
    [J]. RHEUMATOLOGY, 2024, 63 (10) : 2799 - 2809
  • [49] EFFICACY OF BARICITINIB IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS WITH 3 YEARS OF TREATMENT: RESULTS FROM A LONG-TERM STUDY
    Smolen, J. S.
    Xie, L.
    Jia, B.
    Taylor, P. C.
    Burmester, G. R.
    Tanaka, Y.
    Elias, A.
    Cardoso, A.
    Ortmann, R.
    Walls, C.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1012 - 1012
  • [50] Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a phase II study
    Reich, K.
    Bissonnette, R.
    Menter, A.
    Klekotka, P.
    Patel, D.
    Li, J.
    Tuttle, J.
    Papp, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E249 - E249